264 related articles for article (PubMed ID: 32228504)
1. Searching for novel multimodal treatments in oligometastatic pancreatic cancer.
Filippini DM; Grassi E; Palloni A; Carloni R; Casadei R; Ricci C; Serra C; Ercolani G; Brandi G; Di Marco M
BMC Cancer; 2020 Mar; 20(1):271. PubMed ID: 32228504
[TBL] [Abstract][Full Text] [Related]
2. Long-term survival following hepatectomy, radiation, and chemotherapy for recurrent pancreatic carcinoma: a case report.
Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
World J Surg Oncol; 2017 Aug; 15(1):157. PubMed ID: 28835248
[TBL] [Abstract][Full Text] [Related]
3. Liver metastases from gastric carcinoma: A Case report and review of the literature.
Polkowska-Pruszyńska B; Rawicz-Pruszyński K; Ciseł B; Sitarz R; Polkowska G; Krupski W; Polkowski WP
Curr Probl Cancer; 2017; 41(3):222-230. PubMed ID: 28625333
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of a patient with advanced pancreatic cancer under adjunct treatment with
Werthmann PG; Kempenich R; Lang-Avérous G; Kienle GS
World J Gastroenterol; 2019 Mar; 25(12):1524-1530. PubMed ID: 30948915
[TBL] [Abstract][Full Text] [Related]
5. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
6. A case of metastatic pancreatic adenocarcinoma with prolonged survival after combination of neoadjuvant FOLFIRINOX therapy and synchronous distal pancreatectomy and hepatectomy.
Neofytou K; Giakoustidis A; Smyth EC; Cunningham D; Mudan S
J Surg Oncol; 2015 May; 111(6):768-70. PubMed ID: 25556724
[TBL] [Abstract][Full Text] [Related]
7. Use of percutaneous drainage to treat hepatic abscess after radiofrequency ablation of metastatic pancreatic adenocarcinoma.
Thomas KT; Bream PR; Berlin J; Meranze SG; Wright JK; Chari RS
Am Surg; 2004 Jun; 70(6):496-9. PubMed ID: 15212401
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of radiofrequency ablation with aflibercept and FOLFIRI in a patient with metastatic colorectal cancer.
Agarwal A; Daly KP; Butler-Bowen H; Saif MW
Anticancer Res; 2014 Nov; 34(11):6775-8. PubMed ID: 25368290
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection after preoperative chemoradiotherapy benefits selected patients with unresectable pancreatic cancer.
Aristu J; Cañón R; Pardo F; Martínez-Monge R; Martin-Algarra S; Manuel Ordoñez J; Villafranca E; Moreno M; Cambeiro M; Azinovic I
Am J Clin Oncol; 2003 Feb; 26(1):30-6. PubMed ID: 12576921
[TBL] [Abstract][Full Text] [Related]
11. Successful management of metachronous liver metastasis after pancreaticoduodectomy for pancreatic ductal carcinoma using hepatectomy and chemotherapy: a case report.
Iida T; Nakabayashi Y; Okui N; Shiba H; Otsuka M; Yanaga K
Anticancer Res; 2014 May; 34(5):2417-20. PubMed ID: 24778053
[TBL] [Abstract][Full Text] [Related]
12. [Long-Term Survival after Liver and Pulmonary Metastasectomy Following Chemotherapy for Metastatic Pancreatic Ductal Adenocarcinoma-A Case Report].
Aizawa K; Takizawa K; Kawachi Y; Abe S; Ando T; Hirose Y; Ishikawa H; Sakata J; Muneoka Y; Kano Y; Tajima Y; Ichikawa H; Nakano M; Shimada Y; Wakai T
Gan To Kagaku Ryoho; 2024 Jan; 51(1):72-74. PubMed ID: 38247096
[TBL] [Abstract][Full Text] [Related]
13. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
Murphy JE; Wo JY; Ryan DP; Jiang W; Yeap BY; Drapek LC; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Faris JE; Zhu AX; Goyal L; Lillemoe KD; DeLaney TF; Fernández-Del Castillo C; Ferrone CR; Hong TS
JAMA Oncol; 2018 Jul; 4(7):963-969. PubMed ID: 29800971
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
15. FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre.
Pouypoudat C; Buscail E; Cossin S; Cassinotto C; Terrebonne E; Blanc JF; Smith D; Marty M; Dupin C; Laurent C; Dabernat S; Chiche L; Vendrely V
Dig Liver Dis; 2019 Jul; 51(7):1043-1049. PubMed ID: 31000479
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.
Lin C; Verma V; Lazenby A; Ly QP; Berim LD; Schwarz JK; Madiyalakan M; Nicodemus CF; Hollingsworth MA; Meza JL; Are C; Padussis J; Grem JL
Am J Clin Oncol; 2019 Oct; 42(10):755-760. PubMed ID: 31513018
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy in combination with stereotactic body radiation therapy (SBRT) for oligometastatic pancreatic cancer.
Vorobyov N; Rykov I; Orlova R; Cherkashin M
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30219780
[TBL] [Abstract][Full Text] [Related]
18. CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX.
Tanaka M; Heckler M; Mihaljevic AL; Sun H; Klaiber U; Heger U; Büchler MW; Hackert T
Eur J Surg Oncol; 2019 Aug; 45(8):1453-1459. PubMed ID: 30981446
[TBL] [Abstract][Full Text] [Related]
19. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
[TBL] [Abstract][Full Text] [Related]
20. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy.
Carducci MA; Abrams RA; Yeo CJ; Hruban RH; Zahurak ML; Cameron JL; Grochow LB
Int J Radiat Oncol Biol Phys; 1996 Apr; 35(1):143-50. PubMed ID: 8641911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
